First Bankers Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$515K Sell
21,370
-133
-0.6% -$3.48K 0.16% 107
2026
Q1
$604K Sell
21,503
-692
-3% -$18.4K 0.2% 100
2025
Q4
$553K Buy
22,195
+144
+0.7% +$3.63K 0.19% 100
2025
Q3
$562K Sell
22,051
-200
-0.9% -$4.94K 0.2% 101
2025
Q2
$539K Sell
22,251
-3,043
-12% -$71K 0.2% 95
2025
Q1
$641K Sell
25,294
-882
-3% -$23.1K 0.25% 93
2024
Q4
$694K Sell
26,176
-970
-4% -$26.3K 0.27% 87
2024
Q3
$786K Sell
27,146
-1,703
-6% -$49.7K 0.3% 80
2024
Q2
$807K Sell
28,849
-3,604
-11% -$99.2K 0.33% 74
2024
Q1
$901K Sell
32,453
-8,058
-20% -$224K 0.38% 70
2023
Q4
$1.17M Sell
40,511
-8,691
-18% -$263K 0.54% 61
2023
Q3
$1.63M Sell
49,202
-2,312
-4% -$81.8K 0.82% 42
2023
Q2
$1.89M Sell
51,514
-28,517
-36% -$1.11M 0.93% 38
2023
Q1
$3.27M Sell
80,031
-368
-0.5% -$15.9K 1.64% 16
2022
Q4
$4.12M Sell
80,399
-443
-0.5% -$21.2K 2.12% 14
2022
Q3
$3.54M Sell
80,842
-2,971
-4% -$144K 2.03% 13
2022
Q2
$4.39M Sell
83,813
-337
-0.4% -$17.2K 2.3% 9
2022
Q1
$4.36M Sell
84,150
-1,442
-2% -$74.8K 2.03% 12
2021
Q4
$5.05M Sell
85,592
-3,145
-4% -$156K 2.23% 10
2021
Q3
$3.82M Sell
88,737
-1,903
-2% -$84.3K 1.92% 14
2021
Q2
$3.55M Sell
90,640
-18,361
-17% -$714K 1.73% 15
2021
Q1
$3.95M Sell
109,001
-14,594
-12% -$518K 1.65% 19
2020
Q4
$4.55M Sell
123,595
-2,703
-2% -$99.1K 1.75% 17
2020
Q3
$4.4M Sell
126,298
-666
-0.5% -$23.4K 1.87% 13
2020
Q2
$3.94M Buy
126,964
+96
+0.1% +$3.26K 1.76% 19
2020
Q1
$3.93M Sell
126,868
-692
-0.5% -$23.6K 2.03% 11
2019
Q4
$4.74M Buy
127,560
+38
+0% +$1.35K 2% 10
2019
Q3
$4.35M Sell
127,522
-229
-0.2% -$8.33K 1.96% 13
2019
Q2
$5.25M Sell
127,751
-278
-0.2% -$11K 2.43% 7
2019
Q1
$5.16M Sell
128,029
-130,642
-51% -$5.23M 2.45% 4
2018
Q4
$10.7M Buy
258,671
+124,593
+93% +$5.17M 2.79% 3
2018
Q3
$5.61M Sell
134,078
-4,841
-3% -$186K 2.67% 4
2018
Q2
$4.78M Sell
138,919
-4,508
-3% -$154K 2.48% 5
2018
Q1
$4.83M Sell
143,427
-1,034
-0.7% -$35.5K 2.54% 7
2017
Q4
$4.96M Buy
144,461
+773
+0.5% +$26.4K 2.45% 7
2017
Q3
$4.87M Buy
143,688
+515
+0.4% +$16.6K 2.52% 7
2017
Q2
$4.56M Sell
143,173
-2,859
-2% -$90.2K 2.46% 8
2017
Q1
$4.74M Sell
146,032
-715
-0.5% -$22.5K 2.59% 5
2016
Q4
$4.52M Sell
146,747
-1,990
-1% -$60.8K 2.51% 9
2016
Q3
$4.78M Sell
148,737
-1,393
-0.9% -$46.6K 2.68% 5
2016
Q2
$5.01M Sell
150,130
-38,566
-20% -$1.23M 2.79% 6
2016
Q1
$5.31M Buy
188,696
+10,971
+6% +$313K 2.22% 9
2015
Q4
$5.44M Sell
177,725
-359
-0.2% -$11.3K 2.37% 7
2015
Q3
$5.31M Sell
178,084
-648
-0.4% -$20.8K 2.45% 5
2015
Q2
$5.69M Buy
178,732
+126
+0.1% +$4.11K 2.41% 6
2015
Q1
$5.89M Buy
178,606
+1,350
+0.8% +$42.9K 2.53% 6
2014
Q4
$5.24M Sell
177,256
-1,340
-0.8% -$38.4K 2.27% 6
2014
Q3
$5.01M Buy
178,596
+2,126
+1% +$59.7K 2.21% 7
2014
Q2
$4.97M Buy
176,470
+3,160
+2% +$90.1K 2.18% 6
2014
Q1
$5.28M Sell
173,310
-1,328
-0.8% -$39.6K 2.46% 5
2013
Q4
$5.08M Buy
174,638
+9,301
+6% +$271K 2.41% 5
2013
Q3
$4.51M Sell
165,337
-310
-0.2% -$8.44K 2.38% 5
2013
Q2
$4.4M Buy
+165,647
New +$4.58M 2.38% 6

Other funds holding PFE

First Bankers Trust's PFE Position: Q2 2026 in Review

First Bankers Trust reduced its Pfizer (PFE) stake by 0.62% in Q2 2026, selling an estimated $3.48K and leaving 21,370 shares worth $515K. The position accounts for 0.16% of the portfolio, ranked #107.

First Bankers Trust first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.7M in Q4 2018. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • First Bankers Trust held 21,370 shares of Pfizer worth $515K as of Q2 2026.
  • First Bankers Trust sold 133 Pfizer shares in Q2 2026, an estimated $3.48K.
  • Pfizer made up 0.16% of First Bankers Trust's portfolio in Q2 2026, its #107 holding.
  • First Bankers Trust first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • First Bankers Trust's Pfizer position peaked at $10.7M in Q4 2018.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on First Bankers Trust's 13F filing for Q2 2026, filed 9 Jul 2026.